Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom.

Omar A Abdel-MannanCeleste ManchoonThomas RossorJustine-Clair SouthinCarmen TurWallace BrownleeSusan ByrneManali ChitreAlasdair ColesRobert ForsythRachel KneenKshitij MankadDipak RamSiobhan WestSukhvir K WrightEvangeline WassmerMing J LimOlga CiccarelliCheryl HemingwayYael Hacohennull null

Published in: Neurology(R) neuroimmunology & neuroinflammation (2021)

This study provides Class IV evidence that newer DMTs (oral or infusions) are superior to injectables (interferon beta/glatiramer acetate) in reducing both clinical relapses and radiologic activity in children with RRMS.

Keyphrases

multiple sclerosis
white matter
young adults
rheumatoid arthritis
systemic lupus erythematosus